Healthcare advertising is becoming progressively important in the US so as to create awareness about various diseases along with the drugs and procedures required for their treatments. Owing to its growing need and increased government support, the US healthcare advertising market is expected to reach a value of US$ 447 Billion by 2021, growing at a CAGR of 1.5% during 2017-2021. To know more about market, click here: http://www.imarcgroup.com/us-healthcare-advertising-market

1. Copyright © IMARC. All Rights Reserved
US Healthcare Advertising Market: Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2017-2021

2. IMARC is a leading advisor on management strategy and market research worldwide. We partner with
clients in all sectors and regions to identify their highest-value opportunities, address their most
critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food
and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the
company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.
Report DescriptionAbout IMARC Group

3. Report DescriptionReport Description and Highlights
Growth of US Healthcare Advertising Market Driven by Introduction of New Drugs
and Digital Transformation
The US healthcare advertising market witnessed a positive growth owing to increasing direct-to-
consumer (DTC) advertising and introduction of new drugs in market. As a result, the market is
expected to grow at a CAGR of 1.5% during 2017-2021.
According to IMARC Group’s new report, titled “US Healthcare Advertising: Industry Trends,
Share, Size, Growth, Opportunity and Forecast 2017-2021”, the US healthcare advertising market
reached a value of US$ 407 Billion in 2016, growing at a CAGR of 4% during 2009-2016. With the
rising number of new drugs launched in the market, the need to advertise these drugs and widen
the consumer reach has also increased. Healthcare advertising is becoming progressively
important in the US so as to create awareness about various diseases along with the drugs and
procedures required for their treatments. Owing to its growing need and increased government
support, the US healthcare advertising market is expected to reach a value of US$ 447 Billion by
2021, growing at a CAGR of 1.5% during 2017-2021.
Read complete report with TOC: http://www.imarcgroup.com/us-healthcare-advertising-
market

4. Report DescriptionReport Description and Highlights

5. Report Description
Report Description and Highlights
Highlights of the US healthcare advertising market:
• Biopharmaceutical advertising sector represents the fastest growing segment.
• Detailed advertising is the preferred channel of healthcare advertising.
• Major pharmaceutical companies have started investing in DTC advertising, owing to increased
competition in market.
The US healthcare industry is digitally transforming with the introduction of electronic health
records, telemedicine and remote medical monitoring system. Also, consumers and healthcare
providers spend most of their time online on social networking sites. Therefore, digital advertising is
steadily becoming an integral part of the US healthcare advertising market. Moreover, increasing
presence of generic drugs has forced pharmaceutical companies to embrace new business strategies
and advertise their products. The US healthcare advertising market is further boosted by
government’s support to direct-to-consumer (DTC) advertising and increasing consumer reach
through various digital platforms.
Request for free sample report or more details, click here:
http://www.imarcgroup.com/request?type=report&id=723&flag=B

6. Report DescriptionReport Description and Highlights
Biopharmaceutical advertising market is the fastest growing segment, followed by over-the-
counter drugs, vaccines and pharmaceuticals (small molecule drugs). Also, due to rising consumer
demand for helpful and educational content in the form of blogs, social media, video and e-mails,
the use of DTC channel is growing rapidly, but detailed advertising is still preferred over DTC
advertising. Some of the major pharmaceutical companies investing in this sector include Johnson
& Johnson, Pfizer, Merck & Co, GlaxoSmithKline, Novartis and Ely Lilly.
The report by IMARC Group has examined the US Healthcare Advertising Market on
the basis of:
Product:
• Pharmaceuticals (Small molecule drugs)
• Biopharmaceuticals
• Vaccines
• Over-the-counter drugs
Key Players:

7. Report DescriptionReport Description and Highlights
• Johnson & Johnson
• Pfizer
• Merck & Co.
• GlaxoSmithKline
• Eli Lilly
• Novartis
• Sanofi
• AstraZeneca
• Roche
• Bayer HealthCare
• Bristol- Myers Squibb
Browse more reports related to technology & media industry:
http://www.imarcgroup.com/categories/technology-market-reports

8. Report DescriptionReport Description and Highlights
© 2017 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

9. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
http://www.imarcgroup.com
Contact Us